Scarica l'app Stockscreener
6.24
0.48%
0.03
Dopo l'orario di chiusura:
6.24
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$6.21
Aprire:
$6.23
Volume 24 ore:
195.01K
Relative Volume:
0.44
Capitalizzazione di mercato:
$117.09M
Reddito:
$107.35M
Utile/perdita netta:
$6.84M
Rapporto P/E:
17.67
EPS:
0.3532
Flusso di cassa netto:
$14.64M
1 W Prestazione:
-6.73%
1M Prestazione:
+31.65%
6M Prestazione:
-47.65%
1 anno Prestazione:
-55.24%
Intervallo 1D:
$6.18
$6.3151
Intervallo di 1 settimana:
$6.13
$6.68
Portata 52W:
$4.54
$22.25
Optimizerx Corp Stock (OPRX) Company Profile
Nome
Optimizerx Corp
Settore
Industria
Telefono
248-651-6558
Indirizzo
260 CHARLES STREET, WALTHAM, MI
Compare OPRX vs VEEV, BTSG, HQY, TEM, TXG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
6.24 | 117.09M | 107.35M | 6.84M | 14.64M | 0.3532 |
VEEV
Veeva Systems Inc
|
186.24 | 30.25B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
72.91 | 14.31B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
94.64 | 7.91B | 1.34B | 230.70M | 440.96M | 2.6695 |
TEM
Tempus Ai Inc
|
42.69 | 7.69B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
46.27 | 5.87B | 638.78M | -22.66M | 122.18M | -0.1744 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-08 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-12-20 | Iniziato | Stephens | Equal-Weight |
| 2024-07-25 | Ripresa | B. Riley Securities | Buy |
| 2024-04-04 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2023-02-02 | Ripresa | B. Riley Securities | Buy |
| 2022-11-01 | Iniziato | Stifel | Buy |
| 2022-07-15 | Iniziato | SVB Leerink | Outperform |
| 2021-10-18 | Ripresa | B. Riley Securities | Buy |
| 2021-04-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2019-01-03 | Iniziato | William Blair | Outperform |
Mostra tutto
Optimizerx Corp Borsa (OPRX) Ultime notizie
TradingKey - TradingKey
OptimizeRx Corp (OPRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
OptimizeRx appoints Sarah Bast as chief marketing officer - Investing.com
OptimizeRx appoints Sarah Bast as chief marketing officer By Investing.com - Investing.com Canada
OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer - The Manila Times
Sarah Bast Brings More Than Two Decades of Pharma Marketing to OptimizeRx - Stock Titan
Royce & Associates (OPRX) discloses 1.09M-share passive stake in OptimizeRx - Stock Titan
Mariyamma Varghese Presti Net Worth (2026) - GuruFocus
OptimizeRx's Q4 Beat: A Closer Look at the Numbers - Kavout | AI
OptimizeRx Company Profile & Introduction - Moomoo
OptimizeRx Corp. Hits New 52-Week Low at $4.54 Amid Market Struggles - MarketsMojo
OptimizeRx stock rises after launching CopayCue product By Investing.com - Investing.com South Africa
OptimizeRx stock rises after launching CopayCue product - Investing.com
OptimizeRx launches CopayCue for prescription savings - Investing.com
OptimizeRx launches CopayCue for prescription savings By Investing.com - Investing.com Nigeria
OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent - The Manila Times
OptimizeRx Launches CopayCue to Deliver Brand Savings Offers at the Point of Prescribing - Quiver Quantitative
OptimizeRx ties copay offers to physician intent at prescribing moment - Stock Titan
OptimizeRx Corporation (OPRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Stifel reiterates Buy on OptimizeRX stock, cites AI tool launch By Investing.com - Investing.com South Africa
OptimizeRx stock rating maintained at Market Outperform by Citizens - Investing.com Nigeria
OptimizeRx Corporation(NasdaqCM: OPRX) dropped from Russell 2000 Dynamic Index - marketscreener.com
OptimizeRx Corp (OPRX) Institutional Confidence - TradingKey
OptimizeRx Announced the Launch of Natural Language Audience Builder - MarTech Cube
OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms - The Manila Times
OptimizeRx Launches AI-Powered Natural Language Audience Builder for DSP and Media Planning Platforms - Quiver Quantitative
Citizens reiterates Market Outperform on OptimizeRX stock at forum By Investing.com - Investing.com Australia
Citizens reiterates Market Outperform on OptimizeRX stock at forum - Investing.com
OptimizeRx Corp (OPRX) Valuation: PE, PB & Fair Value Analysis - TradingKey
OptimizeRx Corp (OPRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
OptimizeRx StockAnalyst expectations and recent price levels on a quiet news day - Ad-hoc-news.de
OptimizeRx Corp (OPRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
OptimizeRx Corp (OPRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
OptimizeRx Corp (OPRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
OptimizeRx (OPRX) Stock Sees Fair Value Cut As Analysts Reset Growth Expectations - Yahoo Finance
OptimizeRx Corp (OPRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
OptimizeRx Corp (OPRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
OptimizeRx Expands EHR Advertising Reach With New DSP Integration - qz.com
OptimizeRx (NASDAQ: OPRX) holders add 1M plan shares, reject evergreen - Stock Titan
OptimizeRx Secures $35 Million Senior Credit Facility to Fuel Growth - citybuzz -
ContactThe Lethbridge HeraldNews and Sports from around Lethbridge - FinancialContent
OPRX SEC FilingsOptimizerx Corp 10-K, 10-Q, 8-K Forms - Stock Titan
OptimizeRx: A Good Business That Has Not Yet Earned Back Investor Trust - Investing.com
OptimizeRx (OPRX) grants 34,517 restricted stock units to director - Stock Titan
[Form 4] OptimizeRx Corp Insider Trading Activity - Stock Titan
OptimizeRx (OPRX) director Gregory Wasson awarded 34,517 restricted stock units - Stock Titan
OptimizeRx (OPRX) director awarded 17,258 restricted stock units in Form 4 filing - Stock Titan
OptimizeRx Corp stock: Q1 earnings beat lifted shares - AD HOC NEWS
Optimizerx Corp Azioni (OPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Optimizerx Corp Azioni (OPRX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Stelmakh Edward | Chief Finance & Strat Officer |
Dec 19 '25 |
Sale |
13.51 |
1,388 |
18,752 |
126,830 |
| Silvestro Stephen L | Chief Executive Officer |
Dec 19 '25 |
Option Exercise |
0.00 |
6,546 |
0 |
195,462 |
| Odence-Ford Marion | Chief Legal & Admin Officer |
Dec 19 '25 |
Option Exercise |
0.00 |
3,928 |
0 |
94,526 |
| Besch Doug | Chief Product & Tech Officer |
Dec 19 '25 |
Option Exercise |
0.00 |
1,964 |
0 |
71,536 |
| Odence-Ford Marion | Chief Legal & Admin Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
6,649 |
0 |
92,550 |
| Silvestro Stephen L | Chief Executive Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
6,649 |
0 |
190,536 |
| Silvestro Stephen L | Chief Executive Officer |
Oct 03 '25 |
Sale |
18.75 |
1,620 |
30,375 |
188,916 |
| Stelmakh Edward | Chief Finance & Strat Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
16,623 |
0 |
127,387 |
| Besch Doug | Chief Product & Tech Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
3,325 |
0 |
70,555 |
| Spangler Patrick D | Director |
Aug 28 '25 |
Sale |
17.49 |
11,120 |
194,489 |
44,215 |
1.99%
2.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):